<DOC>
	<DOC>NCT02778399</DOC>
	<brief_summary>The primary objective of this study is to assess the efficacy and safety of a range of oral doses of OBE2109 versus placebo, in reducing endometriosis associated pain.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis</brief_title>
	<detailed_description>The study is a prospective, dose-finding, randomized, parallel group, double-blind, placebo-controlled phase 2b study investigating the efficacy and safety of OBE2109 in the treatment of 330 women with moderate-to-severe endometriosis associated pain. Subject will be randomized to one of 6 treatment groups in a 1:1:1:1:1:1 ratio (1 placebo group, 5 dose groups with different dosage/regimen).</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Key The subject must have had surgically and if available histologically confirmed pelvic endometriosis up to 7 years before screening. The subject has moderate to severe endometriosisassociated pain during the screening period. The subject has regular menstrual cycles. The subject has a BMI ≥ 18 kg/m2 and ≤ 39 kg/m2 at the screening visit. Key The subject is pregnant or breast feeding or is planning a pregnancy within the duration of the treatment period of the study. The subject had an interventional surgery for endometriosis performed within a period of 60 days before screening. The subject did not respond to prior treatment with gonadotropin releasing hormone (GnRH) agonists or GnRH antagonists for endometriosis. The subject has a history of, or known osteoporosis or other metabolic bone disease. The subject has chronic pelvic pain that is not caused by endometriosis and requires chronic analgesic / therapy, or that would interfere with the assessment of endometriosis related pain.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pelvic Pain</keyword>
	<keyword>Endometriosis</keyword>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Dyspareunia</keyword>
</DOC>